$KANT
KINETA, INC./DE

2021 Q4 Form 10-Q Financial Statement

#000095017021004473 Filed on November 15, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $762.0K $1.635M $3.308M
YoY Change -88.96% -50.57%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.102M $4.513M $4.540M
YoY Change -936.39% -0.59% 44.13%
% of Gross Profit
Research & Development $5.681M $6.624M $5.489M
YoY Change -85.17% 20.68% -45.89%
% of Gross Profit
Depreciation & Amortization $118.0K $138.0K $40.00K
YoY Change -81.56% 245.0% -88.89%
% of Gross Profit
Operating Expenses $10.78M $11.14M $9.214M
YoY Change -69.45% 20.87% -30.72%
Operating Profit -$9.502M -$5.906M
YoY Change 60.89% -55.59%
Interest Expense -$410.0K $454.0K $501.0K
YoY Change -81.19% -9.38% 127.73%
% of Operating Profit
Other Income/Expense, Net $20.00K -$454.0K -$479.0K
YoY Change -50.0% -5.22% -297.93%
Pretax Income -$10.41M -$9.956M -$8.170M
YoY Change -65.92% 21.86% -36.32%
Income Tax
% Of Pretax Income
Net Earnings -$10.41M -$9.956M -$6.385M
YoY Change -65.92% 55.93% -50.25%
Net Earnings / Revenue -1366.27% -608.93% -193.02%
Basic Earnings Per Share -$0.97
Diluted Earnings Per Share -$999.7K -$966.2K -$3.130M
COMMON SHARES
Basic Shares Outstanding 10.31M 10.30M
Diluted Shares Outstanding 10.30M

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $36.50M $46.40M $40.80M
YoY Change -57.21% 13.72% -47.56%
Cash & Equivalents $35.10M $43.50M $27.40M
Short-Term Investments $1.399M $2.899M $5.000M
Other Short-Term Assets $1.207M $1.725M $800.0K
YoY Change -47.52% 115.63% -57.89%
Inventory
Prepaid Expenses
Receivables $5.000M
Other Receivables $0.00
Total Short-Term Assets $42.71M $48.16M $41.60M
YoY Change -51.24% 15.76% -47.8%
LONG-TERM ASSETS
Property, Plant & Equipment $387.0K $487.0K $12.00M
YoY Change -55.72% -95.94% 2486.21%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $366.0K $386.0K
YoY Change -8.5%
Other Assets $928.0K $928.0K $800.0K
YoY Change -59.65% 16.0% 614.29%
Total Long-Term Assets $20.22M $21.67M $12.75M
YoY Change -25.79% 69.91% -11.11%
TOTAL ASSETS
Total Short-Term Assets $42.71M $48.16M $41.60M
Total Long-Term Assets $20.22M $21.67M $12.75M
Total Assets $62.93M $69.82M $54.35M
YoY Change -45.2% 28.46% -42.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.839M $976.0K $882.0K
YoY Change -75.09% 10.66% -78.32%
Accrued Expenses $4.846M $5.412M $3.670M
YoY Change -38.28% 47.47% -42.45%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $369.0K
YoY Change -100.0%
Long-Term Debt Due $5.805M $5.678M
YoY Change 100.8%
Total Short-Term Liabilities $22.66M $17.86M $6.200M
YoY Change -26.57% 188.11% -46.43%
LONG-TERM LIABILITIES
Long-Term Debt $7.357M $8.742M $0.00
YoY Change -44.42%
Other Long-Term Liabilities $9.415M $10.74M $11.10M
YoY Change -35.07% -3.26% -9.76%
Total Long-Term Liabilities $7.357M $8.742M $11.10M
YoY Change -44.42% -21.24% -9.76%
TOTAL LIABILITIES
Total Short-Term Liabilities $22.66M $17.86M $6.200M
Total Long-Term Liabilities $7.357M $8.742M $11.10M
Total Liabilities $39.44M $37.35M $17.30M
YoY Change -32.74% 115.91% -27.67%
SHAREHOLDERS EQUITY
Retained Earnings -$187.3M -$176.9M -$363.6M
YoY Change 26.73% -51.35% 11.94%
Common Stock $11.00K $10.00K
YoY Change 10.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $23.50M $32.47M -$104.0M
YoY Change
Total Liabilities & Shareholders Equity $62.93M $69.82M $54.35M
YoY Change -45.2% 28.46% -42.2%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$10.41M -$9.956M -$6.385M
YoY Change -65.92% 55.93% -50.25%
Depreciation, Depletion And Amortization $118.0K $138.0K $40.00K
YoY Change -81.56% 245.0% -88.89%
Cash From Operating Activities -$8.737M -$8.275M -$7.780M
YoY Change -177.8% 6.36% -25.98%
INVESTING ACTIVITIES
Capital Expenditures -$24.00K -$24.00K
YoY Change -90.4%
Acquisitions
YoY Change
Other Investing Activities $1.623M $5.402M $1.000M
YoY Change -119.79% 440.2% -94.17%
Cash From Investing Activities $1.599M $5.378M $1.000M
YoY Change -118.92% 437.8% -94.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.292M -900.0K -330.0K
YoY Change -102.34% 172.73% -1750.0%
NET CHANGE
Cash From Operating Activities -8.737M -8.275M -7.780M
Cash From Investing Activities 1.599M 5.378M 1.000M
Cash From Financing Activities -1.292M -900.0K -330.0K
Net Change In Cash -8.430M -3.797M -7.110M
YoY Change -114.56% -46.6% -206.76%
FREE CASH FLOW
Cash From Operating Activities -$8.737M -$8.275M -$7.780M
Capital Expenditures -$24.00K -$24.00K
Free Cash Flow -$8.713M -$8.251M
YoY Change -175.9%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001445283
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37695
dei Entity Registrant Name
EntityRegistrantName
YUMANITY THERAPEUTICS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-8436652
dei Entity Address Address Line1
EntityAddressAddressLine1
40 Guest Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 4410
dei Entity Address City Or Town
EntityAddressCityOrTown
Boston
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02135
dei City Area Code
CityAreaCode
617
dei Local Phone Number
LocalPhoneNumber
409-5300
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
YMTX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10308350
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43532000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
80819000
CY2021Q3 us-gaap Marketable Securities
MarketableSecurities
2899000
CY2020Q4 us-gaap Marketable Securities
MarketableSecurities
4498000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1725000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2264000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
48156000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
87581000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
487000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
874000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19864000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
23678000
CY2021Q3 us-gaap Deposit Assets
DepositAssets
386000
CY2020Q4 us-gaap Deposit Assets
DepositAssets
386000
CY2021Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
928000
CY2020Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2066000
CY2020Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
250000
CY2021Q3 us-gaap Assets
Assets
69821000
CY2020Q4 us-gaap Assets
Assets
114835000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
976000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7384000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5412000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7851000
CY2021Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
5678000
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2891000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4909000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4468000
CY2021Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
65000
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
166000
CY2021Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
823000
CY2020Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
8104000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
17863000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
30864000
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
8742000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
13237000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10738000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14479000
CY2021Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
9000
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
48000
CY2021Q3 us-gaap Liabilities
Liabilities
37352000
CY2020Q4 us-gaap Liabilities
Liabilities
58628000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10308350
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10308350
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10193831
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10193831
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
10000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
10000
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
209361000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
204007000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-176902000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-147810000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
32469000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
56207000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
69821000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
114835000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1635000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3308000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7282000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3308000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6624000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5489000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20729000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14457000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4513000
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3725000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15277000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8356000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
11137000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
9214000
us-gaap Operating Expenses
OperatingExpenses
36006000
us-gaap Operating Expenses
OperatingExpenses
22813000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9502000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5906000
us-gaap Operating Income Loss
OperatingIncomeLoss
-28724000
us-gaap Operating Income Loss
OperatingIncomeLoss
-19505000
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
CY2020Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
46000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
72000
CY2021Q3 us-gaap Interest Expense
InterestExpense
454000
CY2020Q3 us-gaap Interest Expense
InterestExpense
501000
us-gaap Interest Expense
InterestExpense
1407000
us-gaap Interest Expense
InterestExpense
1410000
CY2021Q3 ymtx Interest Incomeand Other Income Expense Net
InterestIncomeandOtherIncomeExpenseNet
0
CY2020Q3 ymtx Interest Incomeand Other Income Expense Net
InterestIncomeandOtherIncomeExpenseNet
24000
ymtx Interest Incomeand Other Income Expense Net
InterestIncomeandOtherIncomeExpenseNet
95000
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10304775
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2159403
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9956000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6385000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-29092000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20822000
ymtx Interest Incomeand Other Income Expense Net
InterestIncomeandOtherIncomeExpenseNet
-21000
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1134000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-454000
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-479000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-368000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1317000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-9956000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-6385000
us-gaap Net Income Loss
NetIncomeLoss
-29092000
us-gaap Net Income Loss
NetIncomeLoss
-20822000
CY2021Q3 ymtx Gain On Extinguishment Of Class B Preferred Units
GainOnExtinguishmentOfClassBPreferredUnits
0
ymtx Gain On Extinguishment Of Class B Preferred Units
GainOnExtinguishmentOfClassBPreferredUnits
0
ymtx Gain On Extinguishment Of Class B Preferred Units
GainOnExtinguishmentOfClassBPreferredUnits
6697000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9956000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6385000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-29092000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-14125000
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.97
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.96
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.84
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-6.55
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10239502
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2155276
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-9956000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-6385000
us-gaap Net Income Loss
NetIncomeLoss
-29092000
us-gaap Net Income Loss
NetIncomeLoss
-20822000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
56207000
CY2021Q1 ymtx Adjustments To Common Units Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToCommonUnitsSharebasedCompensationRequisiteServicePeriodRecognitionValue
1407000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-8682000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
48932000
CY2021Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1313000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
57000
CY2021Q2 ymtx Adjustments To Common Units Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToCommonUnitsSharebasedCompensationRequisiteServicePeriodRecognitionValue
1259000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-10454000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-98280000
CY2020Q3 ymtx Adjustments To Common Units Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToCommonUnitsSharebasedCompensationRequisiteServicePeriodRecognitionValue
694000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-6385000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-103971000
us-gaap Profit Loss
ProfitLoss
-29092000
us-gaap Profit Loss
ProfitLoss
-20822000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
9000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
3000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
513000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
577000
ymtx Noncash Lease Expense
NoncashLeaseExpense
3814000
ymtx Noncash Lease Expense
NoncashLeaseExpense
1692000
us-gaap Share Based Compensation
ShareBasedCompensation
3958000
us-gaap Share Based Compensation
ShareBasedCompensation
1766000
ymtx Other Non Cash Expenses
OtherNonCashExpenses
55000
ymtx Other Non Cash Expenses
OtherNonCashExpenses
0
us-gaap Paid In Kind Interest
PaidInKindInterest
412000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
11693000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-40178000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6377000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
11267000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
41107000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
26000
CY2021Q3 ymtx Adjustments To Common Units Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToCommonUnitsSharebasedCompensationRequisiteServicePeriodRecognitionValue
1292000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-9956000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
32469000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-91900000
CY2020Q1 ymtx Adjustments To Common Units Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToCommonUnitsSharebasedCompensationRequisiteServicePeriodRecognitionValue
570000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-7465000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-98795000
CY2020Q2 ymtx Convertiblepreferredstockvalueissueduponconversion
Convertiblepreferredstockvalueissueduponconversion
288000
CY2020Q2 ymtx Gain On Extinguishment Of Units
GainOnExtinguishmentOfUnits
6697000
CY2020Q2 ymtx Adjustments To Common Units Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToCommonUnitsSharebasedCompensationRequisiteServicePeriodRecognitionValue
502000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-6972000
us-gaap Paid In Kind Interest
PaidInKindInterest
387000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1134000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
72000
ymtx Gain On Sale Of Property And Equipment
GainOnSaleOfPropertyAndEquipment
-63000
ymtx Gain On Sale Of Property And Equipment
GainOnSaleOfPropertyAndEquipment
2000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-668000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
1365000
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
0
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
339000
ymtx Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-3300000
ymtx Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-858000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-6417000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
286000
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-2428000
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
683000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-7281000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
3597000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
12875000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
1350000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
114000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
173000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
13000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1494000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2407000
us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
0
us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
21235000
ymtx Proceeds From Paycheck Protection Program Loan
ProceedsFromPaycheckProtectionProgramLoan
0
ymtx Proceeds From Paycheck Protection Program Loan
ProceedsFromPaycheckProtectionProgramLoan
1123000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1313000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
83000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
894000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
103000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
72000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
140000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
264000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
259000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22022000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-38425000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
13238000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
82885000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14246000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
44460000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
27484000
us-gaap Interest Paid Net
InterestPaidNet
326000
us-gaap Interest Paid Net
InterestPaidNet
952000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
9000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0
ymtx Additions To Property And Equipment Under Finance Lease
AdditionsToPropertyAndEquipmentUnderFinanceLease
0
ymtx Additions To Property And Equipment Under Finance Lease
AdditionsToPropertyAndEquipmentUnderFinanceLease
7000
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
0
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
1412000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
10219000
CY2020Q4 ymtx Merger Agreement Exchange Ratio
MergerAgreementExchangeRatio
0.2108
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-10000000.0
us-gaap Net Income Loss
NetIncomeLoss
-29100000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-176900000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods. Significant estimates and assumptions reflected in these condensed consolidated financial statements include, but are not limited to, revenue recognition, the accrual of research and development expenses, the valuation of common units prior to the Merger and the valuation of stock/unit-based awards. The Company</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">bases </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts, and experience. Actual results may differ from those estimates or assumptions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
44500000
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
27500000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43500000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27400000
CY2021Q3 us-gaap Restricted Cash
RestrictedCash
1000000.0
CY2020Q3 us-gaap Restricted Cash
RestrictedCash
100000
CY2021Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
44785000
CY2020Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
83427000
CY2021Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
2899000
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0
CY2021Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2899000
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
4498000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4498000
CY2021Q3 us-gaap Debt Securities Held To Maturity Threshold Period Past Due
DebtSecuritiesHeldToMaturityThresholdPeriodPastDue
P1Y
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1417000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4295000
CY2021Q3 ymtx Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
2568000
CY2020Q4 ymtx Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
1780000
CY2021Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
767000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
987000
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
660000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
789000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5412000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7851000
CY2021Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
14106000
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
16123000
CY2021Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
5678000
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2891000
CY2021Q3 ymtx Debt Instrument Carrying Amount Noncurrent
DebtInstrumentCarryingAmountNoncurrent
8428000
CY2020Q4 ymtx Debt Instrument Carrying Amount Noncurrent
DebtInstrumentCarryingAmountNoncurrent
13232000
CY2021Q3 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
272000
CY2020Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
348000
CY2021Q3 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
586000
CY2020Q4 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
353000
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
8742000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
13237000
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
1374000
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
5805000
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
6341000
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
586000
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
14106000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
0
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0
ymtx Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod
122469
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
17.89
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
23146
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
17.89
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
12271
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
17.89
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
87052
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
17.89
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
944961
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
20.70
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y3M14D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
6522000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
986014
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
15.33
ymtx Share Based Compensation Arrangements By Share Based Payment Award Options Grants Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsWeightedAverageRemainingContractualTerm
P9Y10M28D
ymtx Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodTotalIntrinsicValue
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
9241
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
8.97
ymtx Share Based Compensation Arrangements By Share Based Payment Award Exercise Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementsByShareBasedPaymentAwardExerciseWeightedAverageRemainingContractualTerm
P7Y4M13D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
9000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
139290
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
13.70
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1782444
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
19.01
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y11M1D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1521000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1767444
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
19.03
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y10M24D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
13700000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
13.89
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1292000
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
694000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3958000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1766000
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
12500000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y7M24D
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-9956000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-6385000
us-gaap Net Income Loss
NetIncomeLoss
-29092000
us-gaap Net Income Loss
NetIncomeLoss
-20822000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9956000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6385000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-29092000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-14125000
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10304775
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2159403
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10239502
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2155276
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.97
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.96
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.84
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-6.55
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1882430
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1063988
CY2020Q1 ymtx License Term
LicenseTerm
P3Y
us-gaap Operating Lease Cost
OperatingLeaseCost
4721000
us-gaap Operating Lease Cost
OperatingLeaseCost
2085000
us-gaap Variable Lease Cost
VariableLeaseCost
458000
us-gaap Variable Lease Cost
VariableLeaseCost
244000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
133000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
280000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
6000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
16000
ymtx Finance Lease Cost
FinanceLeaseCost
139000
ymtx Finance Lease Cost
FinanceLeaseCost
296000
us-gaap Operating Lease Payments
OperatingLeasePayments
4484000
us-gaap Operating Lease Payments
OperatingLeasePayments
1428000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
6000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
16000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
140000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
264000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
10219000
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y5M19D
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y6M29D
CY2021Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y11M26D
CY2020Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y9M29D
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0910
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0880
CY2021Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0559
CY2020Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0690
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1514000
CY2021Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
26000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6173000
CY2021Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
50000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2977000
CY2021Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
0
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1931000
CY2021Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
0
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1985000
CY2021Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
0
CY2021Q3 ymtx Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
4840000
CY2021Q3 ymtx Finance Lease Liability Payments Due After Year Four
FinanceLeaseLiabilityPaymentsDueAfterYearFour
0
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
19420000
CY2021Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
76000
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3773000
CY2021Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
2000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
15647000
CY2021Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
74000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19864000
CY2021Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
66000
CY2021Q3 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
19930000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4909000
CY2021Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
65000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10738000
CY2021Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
9000
CY2021Q3 us-gaap Capital Lease Obligations
CapitalLeaseObligations
15721000
ymtx Term Of Agreement
TermOfAgreement
P9M
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0
CY2021Q3 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0

Files In Submission

Name View Source Status
0000950170-21-004473-index-headers.html Edgar Link pending
0000950170-21-004473-index.html Edgar Link pending
0000950170-21-004473.txt Edgar Link pending
0000950170-21-004473-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ymtx-20210930.htm Edgar Link pending
ymtx-20210930.xsd Edgar Link pending
ymtx-20210930_cal.xml Edgar Link unprocessable
ymtx-20210930_def.xml Edgar Link unprocessable
ymtx-20210930_htm.xml Edgar Link completed
ymtx-20210930_lab.xml Edgar Link unprocessable
ymtx-20210930_pre.xml Edgar Link unprocessable
ymtx-ex31_1.htm Edgar Link pending
ymtx-ex31_2.htm Edgar Link pending
ymtx-ex32_1.htm Edgar Link pending